CombiGene AB (OSTO:COMBI) Stock Based Compensation : kr0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is CombiGene AB Stock Based Compensation?

CombiGene AB's Stock Based Compensation for the three months ended in Dec. 2024 was kr0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

CombiGene AB Stock Based Compensation Historical Data

The historical data trend for CombiGene AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CombiGene AB Stock Based Compensation Chart

CombiGene AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Stock Based Compensation

Get a 7-Day Free Trial

CombiGene AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Stock Based Compensation	Get a 7-Day Free Trial															-	-	-	-	-

CombiGene AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

CombiGene AB Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of CombiGene AB's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

CombiGene AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CombiGene AB (OSTO:COMBI) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Agavagen 52A, Lidingo, SWE, SE-181 55

Website

https://www.combigene.com

CombiGene AB is a gene therapy explorer based in Sweden. The company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present. It develops gene therapies with the ambition to offer patients affected by severe life-changing diseases opportunities for a better life.

CombiGene AB Headlines

No Headlines